Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

21 Oct 2010 07:00

RNS Number : 7190U
Impellam Group plc
21 October 2010
 



Impellam Group plc

("Impellam", the "Company" or the "Group")

 

Trading Update

 

On 6 August 2010 the Company announced its unaudited interim results for the 26 weeks ended 2 July 2010 which stated that operating profit had increased to £12.5m (2009 £0.5m). Net debt had decreased by £30.4 million to £39.2 million as at 2 July 2010 as a result of significant cash generation for the period.

 

Since the interim period end, Impellam has continued to see improved operating performance consistent with the trends experienced during the first half of the year. Net debt stands at £28.5m at 1 October 2010.

 

Cheryl Jones, Chairman, commented:

 

"For the trading period following the Groups half year end, the Company has seen operating performance improvement consistent with that experienced during the first half of the year. Efficiency programs and business rationalization have continued across the Group, and the Company continues to prioritize key drivers of our plan which include leveraging our brands, further improving our process and technology environments, investing in service innovation and refining our growth strategy."

 

 

Enquiries: For any further information please contact:

Impellam Group plc

Cheryl Jones, Chairman

Andrew Burchall, Group Finance Director

Tel: 01582 692658

Tel: 01582 692658

Cenkos Securities plc (Nominated Advisor and Broker to Impellam)

Nicholas Wells

Elizabeth Bowman

Tel: 020 7397 8900

Tel: 020 7397 8900

 

 

Note to Editors:

Impellam is traded on AIM (Symbol: IPEL) and is a leading provider of staffing solutions, human capital management and outsourced people-related services with established operations in the UK, Ireland, USA, mainland Europe, Australia and New Zealand.

 

Business Segment

Staffing Sectors/Brands

Healthcare Staffing

The Group's Healthcare staffing segment comprises Medacs Healthcare (locum doctors, nursing, international recruitment and managed healthcare services) and Chrysalis Homecare (domiciliary care).

UK Staffing - Commercial

 

The Group's UK Commercial staffing segment primarily includes those brands that operate in the traditional clerical, administrative, industrial/trades and hospitality staffing markets. These principal brands include ABC Contract Services (construction and telecoms), Blue Arrow (catering, managed services, office and industrial), Carlisle Managed Solutions (managed services), Comensura (vendor neutral staffing & recruitment procurement), and Tate (office).

UK Staffing - Professional & Technical

 

The Group's UK Professional & Technical staffing segment comprises the following principal brands: Austin Benn (sales and marketing), Celsian Education (teachers and school support staff), Chadwick Nott (legal), Hewitson Walker (accounting), IRC (multi-sector staffing in Ireland), S∙COM (technical) and SRG (scientific).

US Staffing

The Group's US staffing segment operates across a wide spectrum of staffing sectors. The principal brands and their specialties include CORESTAFF Services and Leafstone (Call centre/customer care, engineering, IT, light industrial, office/clerical, professional, skilled trade and technical), Guidant Group (managed services), InfoCurrent (information/records management and library services), S∙COM (technical and telecom) and SRG Woolf (clinical research).

Support Services

The Group's Support services segment consists of several brands providing a wide range of outsourced services to clients throughout the UK. These brands include Carlisle Cleaning & Support Services (contract cleaning and facility support services), Carlisle Security (security guarding and CCTV public space surveillance), and the Recruit (retail merchandising and events).

 

- END-

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXBLFLBBFLFBE
Date   Source Headline
22nd Mar 20247:00 amRNSCancellation - IMPELLAM GROUP PLC
21st Mar 202410:36 amRNSScheme of Arrangement becomes Effective
21st Mar 20247:30 amRNSSuspension - Impellam Group plc
19th Mar 20243:59 pmRNSCourt Sanction of the Scheme of Arrangement
18th Mar 20246:00 pmRNSImpellam Group
15th Mar 202411:46 amRNSForm 8.3 - Impellam Group PLC
15th Mar 202410:58 amRNSForm 8.5 (EPT/RI)
15th Mar 20248:36 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Mar 20247:00 amRNSBidco Share Capital Adjustments
14th Mar 20243:30 pmRNSForm 8.3 - IPEL LN
14th Mar 202412:10 pmRNSForm 8.3 - Impellam Group PLC
14th Mar 20248:30 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
12th Mar 20247:00 amRNSUpdate on Declaration of Dividend in Specie
11th Mar 20241:48 pmRNSForm 8.3 - Impellam Groupl plc
4th Mar 20247:00 amRNSUpdate on Offer Conditions and Timetable
27th Feb 20248:17 amRNSForm 8.5 (EPT/RI)
27th Feb 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
26th Feb 20243:27 pmRNSForm 8.3 - Impellam Group Plc
23rd Feb 20242:44 pmRNSForm 8.5 (EPT/RI)
23rd Feb 20247:22 amRNSTransaction in Own Shares & Rule 2.9 Announcement
22nd Feb 20249:10 amRNSForm 8.5 (EPT/RI)
21st Feb 20243:46 pmRNSUpdate on Offer Conditions
21st Feb 202410:09 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
15th Feb 202410:12 amRNSForm 8.3 - Impellam Group Plc
14th Feb 20241:06 pmRNSForm 8.3 - Impellam Group Plc
14th Feb 20247:41 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
13th Feb 202411:21 amRNSForm 8.3 - Impellam Group PLC
8th Feb 20247:00 amRNSDeclaration of Dividend in Specie
7th Feb 20242:21 pmRNSForm 8.3 - Impellam Group PLC
1st Feb 202412:12 pmRNSForm 8.3 - Impellam Group PLC
1st Feb 202411:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
25th Jan 202410:29 amRNSForm 8.5 (EPT/RI)
25th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Jan 20247:00 amRNSSpecial Cash Dividend Declaration
23rd Jan 202411:56 amRNSForm 8.5 (EPT/RI)
23rd Jan 20248:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
23rd Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
22nd Jan 20249:27 amRNSForm 8.5 (EPT/RI)
22nd Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
19th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
19th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
18th Jan 202411:08 amRNSForm 8.5 (EPT/RI)
18th Jan 20249:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
18th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
17th Jan 20245:01 pmRNSResults of Court Meeting and General Meeting
16th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
12th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
11th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
11th Jan 20242:05 pmRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.